Who is sponsoring NCT03185286?

NCT03185286 is sponsored by Southwest Hospital, China.

What drugs are being tested in NCT03185286?

Interventions in NCT03185286: 3d-printed personalized metal implant.

What condition does NCT03185286 study?

NCT03185286 studies Bone Diseases.

Is NCT03185286 still recruiting?

NCT03185286 is currently status unknown. Last updated 14 June 2017.

Last reviewed 2017-06-14 · How we verify

NCT03185286

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3D-Printed Personalized Metal Implant in Surgical Treatment of Ankle Bone Defects

Status unknown NA Last updated 14 June 2017

What this trial tests

NA trial testing 3d-printed personalized metal implant in Bone Diseases in 40 participants. Status unknown.

Timeline

31 December 2015

Primary endpoint
31 December 2018

31 December 2019

Quick facts

Lead sponsor	Southwest Hospital, China
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	31 December 2015
Primary completion	31 December 2018
Estimated completion	31 December 2019
Sites	1 location across China

Drugs / interventions tested

3d-printed personalized metal implant

Conditions studied

Bone Diseases — all drugs for Bone Diseases →

Sponsor

Southwest Hospital, China

Who can join

14 and older, any sex, with Bone Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to use 3D-printed personalized metal implants for bone defect surgeries in order to reduce pain of the patients.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives.
Ho-Shui-Ling A, Bolander J, Rustom LE, Johnson AW, et al · · 2018 · cited 606× · PMID 30036727 · DOI 10.1016/j.biomaterials.2018.07.017
Poly(lactic-<i>co</i>-glycolic acid)-based composite bone-substitute materials.
Zhao D, Zhu T, Li J, Cui L, et al · · 2021 · cited 238× · PMID 32954053 · DOI 10.1016/j.bioactmat.2020.08.016
Additive Manufacturing of Material Scaffolds for Bone Regeneration: Toward Application in the Clinics.
Garot C, Bettega G, Picart C. · · 2021 · cited 94× · PMID 33531885 · DOI 10.1002/adfm.202006967
From ideas to long-term studies: 3D printing clinical trials review.
Witowski J, Sitkowski M, Zuzak T, Coles-Black J, et al · · 2018 · cited 39× · PMID 29790077 · DOI 10.1007/s11548-018-1793-8

Verify or expand the search:

Other recruiting trials for Bone Diseases

Currently open trials in the same condition.

NCT06745791 — Clinical Validation of BoneMRI in the Spine · recruiting
NCT03571191 — Denosumab Treatment for Fibrous Dysplasia · Phase 2 · active not recruiting

Other Southwest Hospital, China trials

Trials by the same sponsor.

NCT07469293 — Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke · Phase 3 · not yet recruiting
NCT07294209 — Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients · Phase 4 · recruiting
NCT07251374 — Osteomyelitis Multi-center Prospective Cohort Study · not yet recruiting
NCT06894433 — Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage · NA · recruiting
NCT06791538 — Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03185286 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Southwest Hospital, China
Last refreshed: 14 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03185286.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing